| Divinity and the “big three” explanations of suffering R Shweder, N Much, M Mahapatra, L Park Morality and health 119, 119-169, 1997 | 2125* | 1997 |
| Glutamate and gamma-aminobutyric acid systems in the pathophysiology of major depression and antidepressant response to ketamine M Lener, M Niciu, E Ballard, M Park, L Park, A Nugent, C Zarate Biological Psychiatry, 2016 | 418 | 2016 |
| Depression in the Primary Care Setting LT Park, CA Zarate Jr New England Journal of Medicine 380 (6), 559-568, 2019 | 386 | 2019 |
| Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects AC Nugent, ED Ballard, TD Gould, LT Park, R Moaddel, NE Brutsche, ... Molecular psychiatry, 1, 2018 | 209 | 2018 |
| Transcranial magnetic stimulation of the brain: guidelines for pain treatment research MM Klein, R Treister, T Raij, A Pascual-Leone, L Park, et al. Pain, 2015 | 183 | 2015 |
| Default mode connectivity in major depressive disorder measured up to 10 days after ketamine administration JW Evans, J Szczepanik, N Brutsché, LT Park, AC Nugent, CA Zarate Jr Biological psychiatry 84 (8), 582-590, 2018 | 141 | 2018 |
| Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression MJ Niciu, BJ Shovestul, BA Jaso, C Farmer, DA Luckenbaugh, ... Journal of affective disorders 232, 310-315, 2018 | 123 | 2018 |
| Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials ED Ballard, K Wills, N Lally, EM Richards, DA Luckenbaugh, T Walls, ... Journal of affective disorders 218, 195-200, 2017 | 111 | 2017 |
| Shattering Culture: American Medicine Responds to Cultural Diversity MJ Good, S Hannah, S Willen, L Park Russel Sage Foundation, 2011 | 97 | 2011 |
| Novel glutamatergic modulators for the treatment of mood disorders: current status ID Henter, LT Park, CA Zarate Jr CNS drugs 35 (5), 527-543, 2021 | 90 | 2021 |
| Parsing the heterogeneity of depression: An exploratory factor analysis across commonly used depression rating scales ED Ballard, JS Yarrington, CA Farmer, MS Lener, B Kadriu, N Lally, ... Journal of affective disorders 231, 51-57, 2018 | 84 | 2018 |
| Comprehensive assessment of side effects associated with a single dose of ketamine in treatment-resistant depression EE Acevedo-Diaz, GW Cavanaugh, D Greenstein, C Kraus, B Kadriu, ... Journal of Affective Disorders 263, 568-575, 2020 | 83 | 2020 |
| Motor-Activity markers of circadian timekeeping are related to ketamine’s rapid antidepressant properties WC Duncan Jr, E Slonena, NS Hejazi, N Brutsche, CY Kevin, L Park, ... Biological psychiatry 82 (5), 361-369, 2017 | 83 | 2017 |
| Anxiety disorder presentations in Asian populations: a review DE Hinton, L Park, C Hsia, S Hofmann, MH Pollack CNS neuroscience & therapeutics 15 (3), 295-303, 2009 | 81 | 2009 |
| Morality and health RA Shweder, NC Much, M Mahapatra, L Park, A Brandt, P Rozin A. Brandt & P. Rozin (Eds.), 119-169, 1997 | 72 | 1997 |
| Ketamine and serotonergic psychedelics: common mechanisms underlying the effects of rapid-acting antidepressants B Kadriu, M Greenwald, ID Henter, JR Gilbert, C Kraus, LT Park, ... International Journal of Neuropsychopharmacology 24 (1), 8-21, 2021 | 71 | 2021 |
| Antisuicidal response following ketamine infusion is associated with decreased nighttime wakefulness in major depressive disorder and bipolar disorder J Vande Voort, E Ballard, D Luckenbaugh, RA Bernett, EM Richards, ... J Clin Psychiatry, 2016 | 66 | 2016 |
| Ketamine metabolites, clinical response, and gamma power in a randomized, placebo-controlled, crossover trial for treatment-resistant major depression CA Farmer, JR Gilbert, R Moaddel, J George, L Adeojo, J Lovett, ... Neuropsychopharmacology 45 (8), 1398-1404, 2020 | 62 | 2020 |
| Ketamine treatment for depression: a review M Yavi, H Lee, ID Henter, LT Park, CA Zarate Jr Discover Mental Health 2 (1), 9, 2022 | 60 | 2022 |
| Acute ketamine administration corrects abnormal inflammatory bone markers in major depressive disorder B Kadriu, PW Gold, DA Luckenbaugh, MS Lener, ED Ballard, MJ Niciu, ... Molecular psychiatry 23 (7), 1626-1631, 2018 | 59 | 2018 |
Carlos ZarateNational Institute of Mental HealthVerified email at mail.nih.gov
